Connect with us

Top Stories

Common allergy medication’s risks outweigh its usefulness, experts say

Published

on


When it comes to treating an allergic reaction to food with Benadryl, this doctor says, “It’s time to move on.”


A consumer OTC medicine group notes that products containing diphenhydramine “are not intended for long-term use.”

(CNN) — Dr. Anna Wolfson says she sees dangerous misuse of the allergy medication diphenhydramine in her clinic every day.

“If someone has an allergic reaction to a food, people will say, ‘Don’t worry, I have diphenhydramine in my purse,’ and I would say, ‘Really, epinephrine is the first-line treatment for food allergies,’” said Wolfson, an allergist at Massachusetts General Hospital.

Diphenhydramine can be harmful if people take it after having an allergic reaction to food, she said, because the drug – best known by the brand name Benadryl – makes them drowsy and can cause them to miss signs that their symptoms are getting worse.

“It’s time to move on. For every single indication that people are using diphenhydramine, there are better drugs that are more effective at treating the symptoms people are trying to treat with fewer side effects,” she said. “I’ve had patients where I worried that diphenhydramine was impairing their ability to drive or fully participate in their daily lives.”

Wolfson isn’t alone in preferring alternatives. In a review published in February, allergy experts from Johns Hopkins University and the University of California, San Diego called for the removal of diphenhydramine from over-the-counter and prescription markets in the United States, saying it’s outdated, dangerous and eclipsed by safer alternatives.

A first-generation antihistamine approved in 1946, diphenhydramine is widely used for allergies, sleep aid and cold symptoms. It’s a common over-the-counter medication in the US, with usage rising in the summer months as people use it to treat itching from bug bites or poison ivy, as well as sneezing and runny nose caused by grass and pollen allergies, according to the American Pharmacists Association.

Despite its longstanding presence in American homes, the authors of the new review say it poses disproportionate risks, especially for children and older adults, than newer antihistamines.

“Patients should trial alternatives agents like loratadine, which is Claritin, or cetirizine, which is Zyrtec, or fexofenadine, which is Allegra,” to alleviate allergy symptoms, Dr. James Clark of the Department of Otolaryngology-Head and Neck Surgery at the Johns Hopkins University School of Medicine, the lead author of the paper, told CNN.

The Consumer Healthcare Products Association, which represents the OTC medicine industry, says that common side effects associated with products containing diphenhydramine are disclosed on the label. However, it notes, “these products are not intended for long-term use.”

“When used as directed, these medicines provide well-established therapeutic benefits for common health ailments like allergies, the common cold, motion sickness, minor skin irritations, and occasional sleeplessness,” the group said in a statement on behalf of Benadryl’s maker, Kenvue. “Like all medicines, responsible use is essential, and consumers should always follow directions and warnings on the Drug Facts labels and consult healthcare providers if they have questions.”

Risks of diphenhydramine

Antihistamines work by blocking receptors called H1, part of the body’s system for responding to allergens, which trigger symptoms like sneezing, itching and a runny nose. But older drugs like diphenhydramine don’t just block the allergy-related receptors, they can also affect other parts of the brain. Diphenhydramine often causes sedation, cognitive impairment, and in some cases, dangerous cardiac effects, the authors wrote.

In older adults, the drug can stay in the body for up to 18 hours, resulting in lingering sleepiness, disorientation and increasing risk of falling. The review also highlighted a possible link between long-term diphenhydramine use and dementia.

In children, the risks can be even more pronounced. The review’s authors cite cases of accidental overdose; paradoxical reactions such as agitation, extreme sedation and coma; and even death, particularly with pediatric formulations, because of accidental ingestions. The medication was linked to several child hospitalizations and fatalities during the viral “Benadryl Challenge” on TikTok.

Dr. Manuela Murray, director of general pediatrics and urgent care at the University of Texas Medical Branch, says diphenhydramine “should not be used lightly.”

“It should always be used under the guidance of a Medical Professional, and it is only indicated to treat allergic reactions and motion sickness,” Murray wrote in an email.

The medication is often misused and “doesn’t offer a benefit for treatment of cold symptoms, and it is not a safe sleep aid medication,” she said. In fact, it can have the opposite effects in children, leading to hyperactivity.

Dr. Alyssa Kuban, a pediatrician and associate medical director at Texas Children’s Pediatrics, also said that she finds diphenhydramine overused for symptoms it does not directly treat and that there are safer alternatives.

“I see some families use diphenhydramine when the child has a cold or upper respiratory infection, thinking it will help with the congestion and help them to sleep better at night,” she said. “This is not effective for cold symptoms, nor is it very safe.”

She recommends over-the-counter cetirizine to treat children with hives, seasonal allergies or an itchy rash. Cetirizine is also longer-lasting and not as sedating as diphenhydramine, she says.

Murray agrees that loratadine and cetirizine are safer for children over 6 months, and saline drops and suctioning are better alternatives for infants.

‘Time to say a final goodbye’

Diphenhydramine appears in over 300 OTC formulations, often blended into combination products for coughs, colds and flu. The authors of the review say that, like products with pseudoephedrine, diphenhydramine should at minimum be moved behind the counter, allowing pharmacists to guide patients toward second-generation alternatives.

The American Pharmacists Association says patients should use caution with combination cough and cold products that contain diphenhydramine.

Pharmacists may recommend alternative medications for older adults who have a history of being cognitively affected by certain medications, the group says, and it “encourages patients and parents/caregivers to ask their pharmacist for the most appropriate treatment recommendation for their symptoms” with the least amount of side effects.

The review authors also emphasize that there is no strong clinical data that may suggest that diphenhydramine works better than other options. Although it may reduce symptoms like sneezing and itching, it has minimal effect on nasal congestion and doesn’t outperform second-generation drugs in randomized trials. Newer options, such as oral cetirizine, offer 24-hour coverage with fewer adverse events.

However, in the US, the medication remains a staple. According to the review, more than 1.5 million prescriptions are still written annually, not counting untracked OTC purchases.

“In the past, it has been a useful medication that has helped millions of patients; however, its current therapeutic ratio is matched or exceeded by second-generation antihistamines, especially due to their markedly reduced adverse reactions. It is time to say a final goodbye to diphenhydramine, a public health hazard,” the authors wrote.

The-CNN-Wire
™ & © 2025 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Top Stories

US Open live: Aryna Sabalenka v Amanda Anisimova latest score and updates from women’s final

Published

on


Aryna Sabalenka on controlling her emotions in US Open final

:What happened in Paris, definitely not going to happen here and never. I learned that lesson and I will never behave that way. It’s not me.

“I was super emotional. I let it go and let emotions take control over me, and it’s not who I am. It’s never going to happen again.”

Jamie Braidwood6 September 2025 19:01

Aryna Sabalenka vows no repeat of Paris behaviour in US Open final

Aryna Sabalenka has vowed to be gracious whatever happens in her US Open final clash against Amanda Anisimova.

The world number one was heavily criticised for a post-match press conference following her defeat by Coco Gauff in the French Open final, which she attributed to her own errors rather than crediting her opponent.

Sabalenka later apologised publicly and privately, branding the comments “completely unprofessional”.

Jamie Braidwood6 September 2025 18:46

Aryna Sabalenka holds off Jessica Pegula to clinch final return

Aryna Sabalenka is one victory away from retaining her US Open title after winning a pulsating rematch against Jessica Pegula.

The semi-final was a repeat of last year’s final, which Sabalenka won in two tight sets, but this time she had to come from a set down to claim a 4-6 6-3 6-4 win.

Jamie Braidwood6 September 2025 18:31

Amanda Anisimova on coming back from Wimbledon heartache

The manner in which Anisimova reacted to the horror of the Wimbledon final has allowed a mental transformation that may not have occurred without the nightmare of what unfolded eight weeks ago, allowing the resilience she has shown to shine under the pressure of being the last American standing.

“I think it just shows that I have worked really hard, especially on my mental game and not giving up,” Anisimova said. “Like today, I could have easily said, ‘oh, she’s playing better than me, and I can’t really do anything’. I really tried to find any way I could to stay in the match, even though it was extremely tough, and she was playing really great tennis.

“I think I have really worked on myself to really be able to handle those moments and to believe in myself, even when it feels like what is there to believe in, when you’re not playing that well. I think I have really done a better job of that, and especially since the Wimbledon final. I think I have really shifted with my attitude as well.”

Jamie Braidwood6 September 2025 18:15

Amanda Anisimova into ‘dream’ US Open final

Amanda Anisimova is just 24 years old but has just reached back-to-back finals at Wimbledon and the US Open.

She’s the youngest player to do that since Serena Williams in 2002.

“It’s a dream come true,” Anisimova said. “I’ve been dreaming of a US Open final for, like, forever.

“The hope is to be the champion.”

Anisimova pats the court after reaching the US Open final (Getty Images)

Jamie Braidwood6 September 2025 18:09

Amanda Anisimova’s comeback from Wimbledon final defeat

Amanda Anisimova fell to her knees and tapped on the blue hard court. With her dream of reaching a first final at the US Open accomplished, whatever magic that is unfolding in New York had worked its spell again.

Eight weeks after her 6-0 6-0 Wimbledon final defeat to Iga Swiatek, the 24-year-old from New Jersey has given herself another chance to win a grand slam title at the first opportunity. After avenging her defeat to Swiatek in the quarter-finals, Anisimova went one step further by overturning Naomi Osaka’s lead in a back-and-forth semi-final across almost three hours, setting up a final against the World No 1 Aryna Sabalenka.

Jamie Braidwood6 September 2025 18:06

Amanda Anisimova v Aryna Sabalenka set for rematch

A little over eight weeks after they met in the Wimbledon semi-finals, Amanda Anisimova and Aryna Sabalenka will meet again in the US Open final.

Anisimova won that match to deny Sabalenka her first Wimbledon final, and leads the World No 1 in their head-to-head 6-3.

Sabalenka is aiming to become the first player to defend a US Open singles title since Serena Williams in 2014.

(Getty)

Jamie Braidwood6 September 2025 18:05

Anisimova v Sabalenka start time and how to watch US Open final

The US Open women’s final between Amanda Anisimova and Aryna Sabalenka will be played on Saturday 6 September at 4pm local time (9pm UK time).

The men’s final will be played on Sunday 7 September, at the earlier time of 2pm local time (7pm UK time).

How to watch the US Open finals

Sky Sports is showing the US Open in the UK and ESPN in the US.

Amanda Anisimova vs Aryna Sabalenka
Amanda Anisimova vs Aryna Sabalenka (Getty Images)

Jamie Braidwood6 September 2025 18:01

Welcome

Amanda Anisimova plays defending champion Aryna Sabalenka in the US Open women’s final.

Just eight weeks ago, Anisimova lost her first grand slam final 6-0 6-0 at Wimbledon to Iga Swiatek, but the 24-year-old American has put that disappointment behind her to reach her first US Open final.

The eighth seed earned revenge against Swiatek in the quarter-finals then defeated Naomi Osaka in a semi-final thriller to set up the chance for the ultimate redemption against Sabalenka.

Sabalenka is also out for revenge after her defeat to Anisimova in the Wimbledon semi-finals, while the World No 1 aims to become the first player to defend a US Open singles title since Serena Williams in 2014.

Sabalenka is through to a third grand slam final this year, but lost the Australian Open final to Madison Keys and the French Open final to Coco Gauff.

Jamie Braidwood6 September 2025 18:00



Source link

Continue Reading

Top Stories

Red Sea cables are cut, disrupting internet in Asia and the Mideast

Published

on


DUBAI, United Arab Emirates (AP) — Undersea cable cuts in the Red Sea disrupted internet access in parts of Asia and the Middle East, experts said Sunday, though it wasn’t immediately clear what caused the incident.

There has been concern about the cables being targeted in a Red Sea campaign by Yemen’s Houthi rebels, which the rebels describe as an effort to pressure Israel to end its war on Hamas in the Gaza Strip. But the Houthis have denied attacking the lines in the past.

Undersea cables are one of the backbones of the internet, along with satellite connections and land-based cables. Typically, internet service providers have multiple access points and reroute traffic if one fails, though it can slow down access for users.

Microsoft announced via a status website that the Mideast “may experience increased latency due to undersea fiber cuts in the Red Sea.” The Redmond, Washington-based firm did not immediately elaborate, though it said that internet traffic not moving through the Middle East “is not impacted.”

NetBlocks, which monitors internet access, said “a series of subsea cable outages in the Red Sea has degraded internet connectivity in multiple countries,” which it said included India and Pakistan. It blamed “failures affecting the SMW4 and IMEWE cable systems near Jeddah, Saudi Arabia.”

The South East Asia–Middle East–Western Europe 4 cable is run by Tata Communications, part of the Indian conglomerate. The India-Middle East-Western Europe cable is run by another consortium overseen by Alcatel-Lucent. Neither firm did not immediately responded to requests for comment.

Pakistan Telecommunications Co. Ltd., a telecommunication giant in that country, noted that the cuts had taken place in a statement on Saturday.

Saudi Arabia did not immediately acknowledge the disruption and authorities there did not respond to a request for comment.

In the United Arab Emirates, home to Dubai and Abu Dhabi, internet users on the country’s state-owned Du and Etisalat networks complained of slower internet speeds. The government did not immediately acknowledge the disruption.

Subsea cables can be cut by anchors dropped from ships, but can also be targeted in attacks. It can take weeks for repairs to be made as a ship and crew must locate themselves over the damaged cable.

The lines’ cut comes as Yemen’s Houthi rebels remain locked in a series of attacks targeting Israel over the Israel-Hamas war in the Gaza Strip. Israel has responded with airstrikes, including one that killed top leaders within the rebel movement.

In early 2024, Yemen’s internationally recognized government in exile alleged that the Houthis planned to attack undersea cables in the Red Sea. Several were cut, but the Houthis denied being responsible. On Sunday morning, the Houthis’ al-Masirah satellite news channel acknowledged that the cuts had taken place, citing NetBlocks.

From November 2023 to December 2024, the Houthis targeted more than 100 ships with missiles and drones over the Israel-Hamas war in the Gaza Strip. In their campaign so far, the Houthis have sunk four vessels and killed at least eight mariners.

The Iranian-backed Houthis stopped their attacks during a brief ceasefire in the war. They later became the target of an intense weekslong campaign of airstrikes ordered by U.S. President Donald Trump before he declared a ceasefire had been reached with the rebels. The Houthis sank two vessels in July, killing at least four on board, with others believed to be held by the rebels.

The Houthis’ new attacks come as a new possible ceasefire in the Israel-Hamas war remains in the balance. Meanwhile, the future of talks between the U.S. and Iran over Tehran’s battered nuclear program is in question after Israel launched a 12-day war against the Islamic Republic in which the Americans bombed three Iranian atomic sites.





Source link

Continue Reading

Top Stories

Powerball lottery players in Missouri and Texas to split estimated $1.8 billion jackpot

Published

on


DES MOINES, Iowa (AP) — Powerball players in Missouri and Texas won the estimated $1.8 billion jackpot on Saturday, overcoming astronomical odds to end the lottery game’s three-month drought without a big winner.

The winning numbers were 11, 23, 44, 61, and 62, with the Powerball number being 17.

The prize, which was the second-largest U.S. lottery jackpot in history, followed 41 consecutive drawings in which no one matched all six numbers. The last drawing with a jackpot winner happened May 31.

Powerball’s terrible odds of 1 in 292.2 million are designed to generate big jackpots, with prizes growing as they roll over when no one wins. Lottery officials note that the odds are far better for the game’s many smaller prizes. There are three drawings each week.

The estimated $1.8 billion jackpot would go to a winner who opts to receive 30 payments over 29 years through an annuity. Winners almost always choose the game’s cash option, which for Saturday night’s drawing would be an estimated $826.4 million.

Powerball tickets cost $2, and the game is offered in 45 states plus Washington, D.C., Puerto Rico and the U.S. Virgin Islands.





Source link

Continue Reading

Trending